ArticleThe Kaohsiung journal of medical sciences2012

Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.

Chia-Lun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.